Sort
15,842 grants matching “pancreatic cancer”
Comprehensive genetic dissection of druggable KRAS targets
$392,078Steven D Leach · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Comprehensive genetic dissection of druggable KRAS targets
$392,078Steven D Leach · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer
$392,047Hui Mao · Emory University · R01 · FY2012 · CA
Transcription Factor Mutants of Yeast
$391,975Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · GM
TBEL Project 2
$391,973Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Structure and Mechanism of Transcription Factors in Pancreatic Beta Cells
$391,956Scott A Showalter · Pennsylvania State University, The · R01 · FY2020 · DK
High dose radiation therapy to direct immune responses to pancreatic cancer
$391,875Michael James Gough · Providence Portland Medical Center · R01 · FY2021 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$391,875Michael James Gough · Providence Portland Medical Center · R01 · FY2019 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$391,875Michael James Gough · Providence Portland Medical Center · R01 · FY2020 · CA
Molecular Epidemiology of Pancreatic Cancer
$391,860Donghui Li · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$391,766Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$391,697Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$391,654David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Structure and Mechanism of Transcription Factors in Pancreatic Beta Cells
$391,649Scott A Showalter · Pennsylvania State University, The · R01 · FY2021 · DK
Physical Activity, Energy Balance, and Cancer
$391,596Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2018 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2017 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2016 · CA
FOLLOW UP OF THE ALPHA-TOCOPHEROL, BETA-CAROTENE CANCER PREVENTION (ATBC) STUDY
$391,284Jarmo Virtamo · National Research/Dev Ctr/Welfare/Health · N02 · FY2010 · CA
Targeting tumor innate immune signaling in pancreatic cancer
$391,277Kian H Lim · Washington University · R01 · FY2025 · CA
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
$391,244Lily Yang · Emory University · U01 · FY2012 · CA
Center for Modeling Tumor Cell Migration Mechanics: Administrative Core
$391,207David J Odde · University Of Minnesota · U54 · FY2017 · CA
Optimizing the Treatment of Pancreatic Adenocarcinoma
$391,146Chin Hur · Columbia University Health Sciences · R01 · FY2021 · CA
Diabetogenic Molecular I-AG7: Chemistry and Biology
$391,108Emil R Unanue · Washington University · R01 · FY2019 · DK
Diabetogenic Molecular I-AG7: Chemistry and Biology
$391,108Emil R Unanue · Washington University · R01 · FY2018 · DK